Vaxart, Inc. (NASDAQ:VXRT) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...
Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of ...
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the appointment of Adam Zaeske as Executive Vice President and Chief Commercial Officer (CCO), effective March 31, 2025. The ...